UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders

Expert review of hematology, 2023-03, Vol.16 (sup1), p.39-54

2023

Volltextzugriff (PDF)

Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims

Journal of blood medicine, 2020-01, Vol.11, p.1-11

2020

Volltextzugriff (PDF)

Reproductive healthcare utilization in patients with bleeding disorders

Journal of thrombosis and haemostasis, 2023-07, Vol.21 (7), p.1741-1743

2023

Volltextzugriff (PDF)

Unresolved hemostasis issues in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-04, Vol.30 (S3), p.70-77

2024

Volltextzugriff (PDF)

Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.404-407

2023

Volltextzugriff (PDF)

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Blood reviews, 2021-05, Vol.47, p.100759-100759, Article 100759

2021

Volltextzugriff (PDF)

Assessment of menstrual health in adolescent and young adults with sickle cell disease

Pediatric blood & cancer, 2024-01, Vol.71 (1), p.e30727-n/a

2024

Volltextzugriff (PDF)

Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data

Expert review of hematology, 2024-06, Vol.17 (6), p.261-268

2024

Volltextzugriff (PDF)

Thrombin generation and implications for hemophilia therapies: A narrative review

Research and practice in thrombosis and haemostasis, 2023-01, Vol.7 (1), p.100018-100018, Article 100018

2023

Volltextzugriff (PDF)

Depression and anxiety in persons with Von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-03, Vol.29 (2), p.545-554

2023

Volltextzugriff (PDF)

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status

Research and practice in thrombosis and haemostasis, 2021-02, Vol.5 (2), p.342-348

2021

Volltextzugriff (PDF)

von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease

Blood advances, 2024-03, Vol.8 (6), p.1405-1414

2024

Volltextzugriff (PDF)

Procedural outcomes in children with mild type 1 von Willebrand disease

Research and practice in thrombosis and haemostasis, 2024-01, Vol.8 (1), p.102334, Article 102334

2024

Volltextzugriff (PDF)

Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12513-n/a, Article e12513

2021

Volltextzugriff (PDF)

RNAing toward a new therapy for hemophilia

Blood, 2024-05, Vol.143 (22), p.2219-2221

2024

Volltextzugriff (PDF)

Predictors of von Willebrand disease in children

Pediatric blood & cancer, 2012-05, Vol.58 (5), p.736-740

2012

Volltextzugriff (PDF)

Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what’s new on the horizon?

Expert opinion on pharmacotherapy, 2024-07, Vol.25 (11), p.1427-1438

2024

Volltextzugriff (PDF)

A cross‐sectional study of bleeding phenotype in haemophilia A carriers

British journal of haematology, 2015-07, Vol.170 (2), p.223-228

2015

Volltextzugriff (PDF)

Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-09, Vol.25 (5), p.789-796

2019

Volltextzugriff (PDF)

Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-05, Vol.28 (S4), p.18-25

2022

Volltextzugriff (PDF)

Hemophilia B (Factor IX Deficiency)

Hematology/oncology clinics of North America, 2021-12, Vol.35 (6), p.1143-1155

2021

Volltextzugriff (PDF)

Reproductive Health Needs in Patients with Bleeding Disorders

Blood, 2022-11, Vol.140 (Supplement 1), p.7985-7986

2022

Volltextzugriff (PDF)

Substitution therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-02, Vol.27 (S3), p.53-59

2021

Volltextzugriff (PDF)

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort

American journal of hematology, 2023-10, Vol.98 (10), p.E285-E287

2023

Volltextzugriff (PDF)

Plasma factor IX: The tip of the iceberg?

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.329-331

2021

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders

Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims

Reproductive healthcare utilization in patients with bleeding disorders

Unresolved hemostasis issues in haemophilia

Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Assessment of menstrual health in adolescent and young adults with sickle cell disease

Early diagnosis of persons with von Willebrand disease using a machine learning algorithm and real-world data

Thrombin generation and implications for hemophilia therapies: A narrative review

Depression and anxiety in persons with Von Willebrand disease

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status

von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease

Procedural outcomes in children with mild type 1 von Willebrand disease

Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease

RNAing toward a new therapy for hemophilia

Predictors of von Willebrand disease in children

Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what’s new on the horizon?

A cross‐sectional study of bleeding phenotype in haemophilia A carriers

Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis

Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues

Hemophilia B (Factor IX Deficiency)

Reproductive Health Needs in Patients with Bleeding Disorders

Substitution therapy

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort

Plasma factor IX: The tip of the iceberg?

Suchergebnisse filtern